Chindex International, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG And Fosun Pharma

News provided by

Feb 18, 2014, 10:49 ET

NEW YORK, Feb. 18, 2014 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company") (NASDAQ: CHDX) breached its fiduciary duty to its shareholders in agreeing to sell Chindex to a buyer consortium (of an affiliate of TPG (together with its affiliates, "TPG"), an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun"), and Ms. Roberta Lipson, the CEO of the Company.

Under the terms of the agreement, Chindex shareholders will receive $19.50 in cash for each share they own. The investigation is focused on the potential unfairness of the price to Chindex shareholders and the process by which the Chindex Board of Directors considered and approved the transaction.

If you are interested in discussing your rights as a Chindex stockholder, with no obligation or cost to you, please contact U. Seth Ottensoser at:

(877) 779-1414
or
[email protected].

Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal's "Plaintiffs' Hot List" in each of the last eleven years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
www.bernlieb.com

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO

SOURCE Bernstein Liebhard LLP